Music

London Student vs. Felix: Day Eleven – A song from your favourite band

Like, tweet, or comment on this page to help us beat the London Student newspaper on day eleven of our 30-day Song Challenge duel

Kadhim Shubber

30 May 2011

Ok so this unsigned instrumental hip-hop producer from California isn't necessarily my favourite musician of all time. I'm not really sure that I could choose just one artist anyway. However, he is my favourite musician as of 10:27 this morning when former Science Editor Katya-yani Vyas recommended that I listen to his sick album Flavors.

The London Student and Felix are currently fighting an epic war. Like, tweet, or comment on this page to help us win today's battle. Tomorrow is 'A song from a band you hate' – help us choose by posting your suggestions below.

London Student vs. Felix: Day Ten – A song that makes you fall asleep

Like, tweet, or comment on this page to help us beat the London Student newspaper on day ten of our 30-day Song Challenge duel

Animal Collective in Eastbourne. Wait, what?

The sleepy south coast plays host to avant-garde New York collective

Rinse, rave, and repeat

The UK’s premier dance festival, Creamfields, is a true clubber’s paradise says Sean Harbison

Star Slinger

A profile of this year's hottest artist

Societies

The London Neurotech Hackathon

The second edition of the London Neurotech Hackathon took place on the weekend of 21st February, at the headquarters of Entrepreneurs First. Participants, ranging from undergraduates to post-docs and lecturers, came from Imperial and beyond, with some flying in from across Europe for the competition. A flagship event for the

Societies

A capella teams at ICCAs

On Sunday 22nd February, three of Imperial’s a capella groups performed in the UK Championship quarterfinals, one of them qualifying for the semifinals. In first place, with 382 points was Nth Harmonic with their shiny silver outfits; in second place, with 378 points was the Houghtones from LSE; and,

Science

Progress in prostate cancer care

Salvage focal therapy offers renewed hope for men facing recurrent prostate cancer.